⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for non small cell lung cancer

Every month we try and update this database with for non small cell lung cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLCNCT03201146
Lung Cancer
Non Small Cell ...
Combination Che...
Apatinib
Apatinib
AP or AC
Apatinib 250mg
Apatinib 500mg
Apatinib 750mg
18 Years - 70 YearsWest China Hospital
TEIPP Immunotherapy in Patients With NSCLCNCT05898763
Non Small Cell ...
TEIPP24 (LRPAP7...
18 Years - Erasmus Medical Center
Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung CancerNCT00798720
Carcinoma, Non ...
vorinostat
bortezomib
18 Years - University of Wisconsin, Madison
Study of Use of CTC in NSCLCNCT01990651
Non Small Cell ...
Chronic Obstruc...
18 Years - University of Virginia
Anlotinib Combined With Docetaxel for Advanced Non-Small Cell Lung Cancer(ALTER-L034)NCT03735264
Non Small Cell ...
Anlotinib Hydro...
18 Years - 75 YearsThe Affiliated Hospital of Qingdao University
Alvopem® (Pemetrexed) Safety AssessmentNCT04843007
Non Small Cell ...
Malignant Pleur...
Pemetrexed
- NanoAlvand
Lung Heart Rate VariabilityNCT03674450
Non Small Cell ...
Heart Rate Vari...
18 Years - 70 YearsAbramson Cancer Center at Penn Medicine
A Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage Non Small Cell Lung CancerNCT01237171
NSCLC
Non Small Cell ...
Cesium-131 Brac...
- IsoRay Medical, Inc.
Iressa in the Treatment of Brain Metastases From Non Small Cell Lung CancerNCT00234442
Brain Neoplasms
Non Small Cell ...
Iressa (Gefitin...
18 Years - AstraZeneca
Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & ChemotherapyNCT05781308
Non Small Cell ...
Paclitaxel
Bevacizumab
Atezolizumab
18 Years - Intergroupe Francophone de Cancerologie Thoracique
Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung CancerNCT00714246
Non Small Cell ...
Bortezomib
Carboplatin
Docetaxel
18 Years - 90 YearsMilton S. Hershey Medical Center
A Prospective Study of Pembrolizumab Combining Chemotherapy in Advanced NSCLC Patients With EGFR Exon 21 Point Mutation.NCT06142617
Non Small Cell ...
Immune Checkpoi...
EGFR Exon 21 Mu...
Pembrolizumab, ...
Osimertinib
18 Years - Peking Union Medical College Hospital
Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor MalignanciesNCT04383938
Bladder Cancer
Gastric Cancer
Non Small Cell ...
NSCLC
Urothelial Carc...
Advanced Solid ...
APR-246 (eprene...
18 Years - Aprea Therapeutics
A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) in Central Non-Small Cell Lung CancerNCT05138900
Non Small Cell ...
SBRT
18 Years - Roswell Park Cancer Institute
Pembrolizumab and Itacitinib (INCB039110) for Non-Small Cell Lung CancerNCT03425006
Non Small Cell ...
Itacitinib
Pembrolizumab
18 Years - University of Pennsylvania
T790M Mutation Positive 2nd Line STandard of cAre RegistryNCT02368990
Non Small Cell ...
18 Years - AstraZeneca
Continuation of TKI With or Without Chemotherapy Beyond Gradual ProgressionNCT01998061
Non Small Cell ...
EGFR tyrosine k...
EGFR tyrosine k...
18 Years - 75 YearsZhejiang University
BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC)NCT01562028
Lung Cancer
Erlotinib
Bevacizumab
18 Years - ETOP IBCSG Partners Foundation
The Safety and Feasibility of Costal Bone Marrow Aspiration During Thoracic SurgeryNCT05251805
Non Small Cell ...
Blood, bone mar...
18 Years - Universitair Ziekenhuis Brussel
Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung CancerNCT00192036
Non Small Cell ...
gemcitabine
cisplatin
radiation
18 Years - Eli Lilly and Company
Neoadjuvant Therapy in Resectable Non-Small Cell Lung Cancer Stages IIB-IIIBNCT04197076
Non Small Cell ...
anti-PD-1 or an...
EGFR-TKI, ALK i...
investigator de...
18 Years - 75 YearsShanghai Chest Hospital
UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint BlockadeNCT03474497
Non Small Cell ...
Metastatic Mela...
Metastatic Rena...
Head and Neck S...
IL-2
Pembrolizumab
Radiotherapy
18 Years - University of California, Davis
Low Volume High Intensity Interval Training in Operated Lung Cancer PatientsNCT05837429
Lung Cancer
Non Small Cell ...
Low Volume High...
Aerobic Exercis...
18 Years - 80 YearsHacettepe University
Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung CancerNCT05452005
Lung Cancer
Lung Cancer Met...
Brain Metastase...
Non Small Cell ...
[18F]-αvβ6-BP
18 Years - University of California, Davis
Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.NCT05102110
Non Small Cell ...
Gastric Adenoca...
Pancreatic Canc...
Gall Bladder Ca...
Bladder Cancer
Oricol Test
18 Years - 99 YearsOrigin Sciences
A Phase I/II Study of AMG 510 in Combination With MVASI in Patients With Advanced, Unresectable or Metastatic KRAS G12C Mutant NSCLC With Asymptomatic Brain MetastasisNCT05180422
Non Small Cell ...
AMG 510
MVASI
18 Years - Criterium, Inc.
Erlotinib and Sunitinib in NSCLCNCT00581789
Non Small Cell ...
erlotinib, suni...
18 Years - University of Wisconsin, Madison
Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung CancerNCT00753909
Non Small Cell ...
Carboplatin
Bevacizumab
Paclitaxel
18 Years - Hellenic Oncology Research Group
Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT)NCT00462995
Non Small Cell ...
Erlotinib
Erlotinib
18 Years - 95 YearsUniversity Health Network, Toronto
Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)NCT00419042
Non Small Cell ...
TARCEVA
Gemzar
65 Years - Groupe Francais De Pneumo-Cancerologie
A Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage Non Small Cell Lung CancerNCT01237171
NSCLC
Non Small Cell ...
Cesium-131 Brac...
- IsoRay Medical, Inc.
EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC)NCT00879866
Lung Cancer
Non Small Cell ...
EMD 521873
18 Years - Merck KGaA, Darmstadt, Germany
NM404 as an Imaging Agent in Patients With NSCLCNCT00582283
Non Small Cell ...
I124-NM404
18 Years - University of Wisconsin, Madison
A Phase 2 Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTIONNCT04262375
Non Small Cell ...
Renal Cell Carc...
Durvalumab
Oleclumab
18 Years - University Health Network, Toronto
Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) MutationsNCT00891579
Non Small Cell ...
Pemetrexed (Ali...
Gefitinib (IRES...
18 Years - 80 YearsChinese Society of Lung Cancer
Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic PlatformNCT05478538
Non Small Cell ...
Metastatic Non ...
NSCLC
Metastatic NSCL...
Core Needle or ...
18 Years - Elephas
Evaluation of NSCLC Patients' Oxygen Uptake On-kinetics at Cycle-ergometer During PrehabilitationNCT04041297
Non Small Cell ...
Preoperative Pu...
18 Years - ADIR Association
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 RearrangementsNCT03093116
Locally Advance...
Metastatic Soli...
Oral repotrecti...
12 Years - Turning Point Therapeutics, Inc.
Anlotinib Plus Penpulimab in Advanced Non-Small-Cell Lung Cancer Previously Treated With PD-1/PD-L1 InhibitorsNCT05460481
Non Small Cell ...
Anlotinib Plus ...
18 Years - 75 YearsHunan Cancer Hospital
Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer PatientsNCT01749072
Non-small Cell ...
Effects of Chem...
Gefitinib group
Vinorelbine, If...
18 Years - 70 YearsPeking Union Medical College Hospital
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain CancersNCT03190174
Ewing Sarcoma
PEComa
Epithelioid Sar...
Desmoid Tumor
Chordoma
Non Small Cell ...
Urothelial Carc...
Melanoma
Renal Cell Carc...
Squamous Cell C...
Hepatocellular ...
Classical Hodgk...
Colorectal Canc...
MTOR Activating...
Nab-Rapamycin
Nivolumab
12 Years - Sarcoma Oncology Research Center, LLC
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryNCT03452774
Cancer, Metasta...
Cancer
Cancer of Pancr...
Cancer of Liver
Cancer of Stoma...
Cancer Liver
Cancer of Rectu...
Cancer of Kidne...
Cancer of Esoph...
Cancer of Cervi...
Cancer of Colon
Cancer of Laryn...
Cancer, Lung
Cancer, Breast
Cancer, Advance...
Cancer Prostate
Cancer of Neck
Cancer of Skin
Neuroendocrine ...
Carcinoma
Mismatch Repair...
BRCA Gene Rearr...
Non Hodgkin Lym...
Leukemia
Non Small Cell ...
Cholangiocarcin...
Glioblastoma
Central Nervous...
Melanoma
Urothelial Carc...
Bladder Cancer
Ovarian Cancer
Endometrial Can...
Testicular Canc...
Breast Cancer
COVID
Myelofibrosis
Myeloproliferat...
Myeloproliferat...
Follicular Lymp...
Mantle Cell Lym...
Marginal Zone L...
Myelodysplastic...
Clinical Trial ...
- Massive Bio, Inc.
ZD1839 (Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung CancerNCT00252798
Non Small Cell ...
Gefitinib
Carboplatin
Paclitaxel
Radiation
18 Years - AstraZeneca
A Study of CM24 in Combination With Nivolumab in Adults With Advanced Solid TumorsNCT04731467
Solid Tumor
Non Small Cell ...
Pancreatic Canc...
Ovarian Cancer
Papillary Thyro...
Melanoma
Colorectal Aden...
CM-24 and Nivol...
CM-24, Nivoluma...
CM-24, Nivoluma...
Nivolumab, Nab ...
Nivolumab and N...
18 Years - Purple Biotech Ltd.
Quality of Life and Physical Fitness After Immune Checkpoint InhibitorsNCT03946007
Melanoma
Non Small Cell ...
18 Years - University Medical Center Groningen
Incidence and Characterization of Drivers Oncogenes in the Population With Lung Cancer Afferents to the Cancer Institute in Aviano (IN.ON.D.)NCT06180005
Non Small Cell ...
- Centro di Riferimento Oncologico - Aviano
Phase II Lung Metcore - Preoperative Metformin for Lung CancerNCT03086733
Non Small Cell ...
Lung Cancer
Metformin
18 Years - 90 YearsUniversity Health Network, Toronto
Tumor Treating Fields for Locally Advanced NSCLCNCT06124118
Non Small Cell ...
carboplatin che...
NovoTTF-200T (T...
Durvalumab
22 Years - University of Utah
Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)NCT01355484
Muscle Wasting
Non Small Cell ...
GTx-024
placebo
30 Years - GTx
Pembrolizumab + Idelalisib for Lung Cancer StudyNCT03257722
Non Small Cell ...
Metastasis
Recurrence
Pembrolizumab
Idelalisib
18 Years - Augusta University
Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung CancerNCT01090830
Non-Small-Cell ...
Belinostat, car...
18 Years - Holy Cross Hospital, Florida
Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLCNCT00492206
Non Small Cell ...
Cetuximab
18 Years - University of Pittsburgh
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCNCT04140526
Non Small Cell ...
Advanced Solid ...
Metastatic Mela...
Metastatic Head...
Metastatic Rena...
Metastatic Colo...
Sarcomas
Metastatic Pros...
Ovarian Cancer
Small Cell Lung...
Metastatic Brea...
Pancreas Cancer
Gastric Cancer
Esophageal Canc...
Gastroesophagea...
Cervical Cancer
Adenoid Cystic ...
Salivary Gland ...
Urothelial Carc...
ONC-392
Pembrolizumab
Docetaxel
18 Years - OncoC4, Inc.
Integrated Discovery of New Immuno-Molecular Actionable Biomarkers for Tumors With Immune-suppressed EnvironmentNCT03706625
Non Hodgkin Lym...
Non Small Cell ...
Glioma
18 Years - Assistance Publique - Hôpitaux de Paris
This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC.NCT03968419
Non-small Cell ...
Canakinumab
Pembrolizumab
18 Years - Novartis
Vapor Ablation for Localized Cancer LesionsNCT03514329
Non Small Cell ...
Metastatic Lung...
Lung Cancer
Bronchoscopic T...
18 Years - Uptake Medical Technology, Inc.
Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLCNCT04919811
Non Small Cell ...
Taletrectinib
18 Years - AnHeart Therapeutics Inc.
Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung CancerNCT00460551
Non Small Cell ...
Zalutumumab
Induction chemo...
Radiotherapy
18 Years - Genmab
A Study of Personalized Neoantigen Cancer VaccinesNCT03794128
Non Small Cell ...
Colorectal Canc...
Gastroesophagea...
Urothelial Carc...
Pancreatic Duct...
Blood collectio...
Blood collectio...
18 Years - Gritstone bio, Inc.
Atezolizumab and Bevacizumab in EGFR Mutant NSCLC in Patients With Progressive Disease After Receiving OsimertinibNCT04099836
Non Small Cell ...
Atezolizumab
Bevacizumab
18 Years - Duke University
Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung CancerNCT04726215
Non Small Cell ...
[18F]F AraG
18 Years - CellSight Technologies, Inc.
A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLCNCT04636593
Non Small Cell ...
Stage III NSCLC
EGFR Activating...
Almonertinib
18 Years - First People's Hospital of Hangzhou
Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET AlterationsNCT05845671
Lung Cancer
Non Small Cell ...
Amivantamab 105...
Amivantamab 140...
Amivantamab (to...
Amivantamab (to...
18 Years - 90 YearsUniversity of Colorado, Denver
Durvalumab and Stereotactic Radiotherapy for Advanced NSCLCNCT04786093
Non Small Cell ...
Stereotactic ra...
Durvalumab
18 Years - University of Texas Southwestern Medical Center
Study of PX-866 and Docetaxel in Solid TumorsNCT01204099
Non Small Cell ...
Squamous Cell C...
Docetaxel
PX-866
18 Years - Seagen Inc.
Trial-specific Patient Decision Aid (tPDA) of the ImmunoSABR Phase 2NCT04604470
NSCLC Stage IV
Lung Cancer
Non Small Cell ...
Metastatic Canc...
Decision tool
18 Years - Maastricht University
ENCOrafenib With Binimetinib in bRAF NSCLCNCT04526782
Non Small Cell ...
BRAF V600E
Encorafenib 75 ...
Binimetinib 15 ...
18 Years - Intergroupe Francophone de Cancerologie Thoracique
Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)DiseaseNCT01784549
Non Small Cell ...
Cisplatin Docet...
18 Years - IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Combined Application of EBUS and EUS in Lung CancerNCT01385111
Non Small Cell ...
EUS-B-FNA follo...
EBUS-TBNA follo...
18 Years - National Cancer Center, Korea
Neoadjuvant Immunotherapy and Chemotherapy Followed by Surgery in Unresectable Stage Ⅲ NSCLCNCT04943029
Non Small Cell ...
Carrelizumab
Pemetrexed (Non...
Carboplatin
Surgery
18 Years - 70 YearsWuhan Union Hospital, China
An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and NeckNCT00684385
Non Small Cell ...
Cancer of the H...
ZD1839
18 Years - 130 YearsAstraZeneca
Image Mining and ctDNA to Improve Risk Stratification and Outcome Prediction in NSCLC Applying Artificial Intelligence.NCT06163846
Non Small Cell ...
Assess the role...
18 Years - 70 YearsIRCCS San Raffaele
Epidemiologic Study of KRAS Mutation in Brazilian Patients With Advanced or Metastatic Non Small Cell Lung CancerNCT00956280
Non Small Cell ...
18 Years - AstraZeneca
Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone MetastasisNCT00762346
Non Small Cell ...
Bone Metastases
High NTX Level
zometa
18 Years - Sun Yat-sen University
Phase 1/2 Study of MRTX1719 in Solid Tumors With MTAP DeletionNCT05245500
Mesothelioma
Non Small Cell ...
Malignant Perip...
Solid Tumor
Pancreatic Aden...
Advanced Solid ...
MRTX1719
18 Years - Mirati Therapeutics Inc.
SCION: SABR and Checkpoint Inhibition Of NSCLCNCT04944173
Non Small Cell ...
Carcinoma, Non-...
Non-small Cell ...
Lung Cancer
Lung Cancer Sta...
Lung Adenocarci...
Lung Squamous C...
Durvalumab
Stereotactic Bo...
Circulating Tum...
18 Years - University of British Columbia
Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010MA in Advanced Non Small Cell Lung CancerNCT02448251
Non Small Cell ...
AC0010MA
18 Years - ACEA Therapeutics, Inc.
A Study of DSP107 Alone and in Combination With Atezolizumab for Patients With Advanced Solid TumorsNCT04440735
Advanced Solid ...
Non Small Cell ...
Colorectal Canc...
DSP107
Atezolizumab
18 Years - Kahr Medical
Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung CancerNCT01090830
Non-Small-Cell ...
Belinostat, car...
18 Years - Holy Cross Hospital, Florida
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung CancerNCT04614103
Metastatic Non ...
LN-145
LN-145
18 Years - 70 YearsIovance Biotherapeutics, Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: